NEW YORK (GenomeWeb News) — Microarrayer developer Aushon BioSystems has raised $7.8 million in a Series A financing round, the company said today.
Financing company North Bridge Venture Partners led the round, which ended on Oct. 12, Aushon said.
The early stage company, based in Burlington, Mass., makes microarrayers for protein, antibody, and cell research. Its clients include the National Institutes of Health, M.D. Anderson Cancer Center, and George Mason University.